000 | 01030nam a2200181Ia 4500 | ||
---|---|---|---|
005 | 20240321114204.0 | ||
008 | 170106s2007||||xx |||||||||||||| ||und|| | ||
020 |
_a9780080445137 [Set] _qhb |
||
082 |
_a615.19 _bTAY.8v |
||
100 | _aTaylor, John B [ed.] | ||
245 | 0 | _aComprehensive medical chemistry II [8v.] | |
260 |
_aOxford _bElsevier _c2007 |
||
300 | _a8v. (xxvii, 854p.; xxvii, 1169p.; xxix, 1037p.; xxxviii, 853p.; xxix, 1152p.; xxviii, 835p. xxviii, 1032p.; xlvi, 598p.) ; 27cm. | ||
500 | _aContents.- v.1 Global perspective, v.2 Strategy and drug research, v.3 Drug discovery technologies, v.4 Computer assisted drug design, v.5 ADME-Tox approaches, v.6 Therapeutic areas l : central nervous system, pain, metabolic syndrome, urology, gastrointestinal and cardiovascular, v.7 Therapeutic areas l : cancer, infectious disease, inflammation and immunology and dermatology, v.8 Case histories and cumulative subject index. | ||
653 | _aMedical--Chemistry | ||
700 | _aTriggle, David J. [ed.] | ||
942 |
_cBK _2ddc |
||
999 |
_c2256 _d2256 |